Evidence-based educational resources for healthcare providers on cardiogenomic topics.
Factor V Leiden
Point of care tool: Contains when to offer genetic testing and management recommendations for asymptomatic carriers. (Jan 2023)
GECKO on the run: A 3-page, evidence-based summary for healthcare providers. Features a bottom line, red flags to consider genomic consultation or testing, surveillance and management recommendations. (Jan 2023)
GECKO deep dive: A 4-page, comprehensive evidence-based resource for healthcare providers. Features a bottom line, red flags to consider genomic consultation or testing, surveillance and management recommendations, references and more. (Oct 2014)
Familial hypercholesterolemia
Point of care tool: Contains the Canadian criteria for the clinical diagnosis of familial hypercholesterolemia as well as clinical features of the condition. (Jan 2023)
GECKO on the run: A 3-page, evidence-based summary for healthcare providers. Features a bottom line, clinical features, Canadian diagnostic criteria, surveillance and management recommendations. (Nov 2023)
GECKO deep dive: An 8-page, comprehensive evidence-based resource for healthcare providers. Features a bottom line, clinical features, diagnostic criteria, surveillance and management, references and more. (Nov 2023)
Hypertrophic cardiomyopathy
GECKO on the run: A 3-page, evidence-based summary for healthcare providers. Features a bottom line, red flags to consider genetic consultation, benefits and limitations of genetic testing, references and more. (June 2014; under review)
Point of care tool: Outlines the evaluation and management of hypertrophic cardiomyopathy. (June 2014; under review)
Long QT syndrome
GECKO on the run: A 3-page, evidence-based summary for healthcare providers. Features a bottom line, QTc cut-offs, red flags to consider genetic or cardiac consultation, benefits and limitations of genetic testing, surveillance and management, references and more. (Aug 2016; under review)
Point of care tool: Contains a brief overview of long QT syndrome and the red flags for how to identify the condition and the individuals who would most likely to benefit from referral to genetics and a cardiac arrhythmia specialist. (Oct 2016; under review)
